Brain activity of anandamide: a rewarding bliss?

Scherma, M; Masia, P; Satta, V; Fratta, W; Fadda, P; Tanda, G

Tanda, G (reprint author), NIDA, Medicat Dev Program, IRP, NIH,DHHS, 333 Cassell Dr,NIDA Suite 3301, Baltimore, MD 21224 USA.

ACTA PHARMACOLOGICA SINICA, 2019; 40 (3): 309

Abstract

Anandamide is a lipid mediator that acts as an endogenous ligand of CB1 receptors. These receptors are also the primary molecular target responsible f......

Full Text Link